Cancer Epidemiology Biomarkers & Prevention

Papers
(The H4-Index of Cancer Epidemiology Biomarkers & Prevention is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Abstract PR-01: Association of Affordable Care Act Medicaid expansions with healthcare access and utilization among people who smoke168
Abstract PO-053: South Carolina Cancer Disparities Research Center's (SC CADRE) culturally-sensitive, state-of-the-art treatment to eliminate cancer disparities conference77
Abstract PO-061: 'Tu historia cuenta' online version: Promotores' experience and perspectives on the virtual adaption of a hereditary breast cancer education and risk identification program56
Abstract PR-11: Blood levels of TNFRSF9 and PTN predict lethal prostate cancer among African American men46
Abstract PO-115: Defining radiation treatment quality disparities in the COVID-19 Era44
Abstract PO-256: Knowledge and attitudes of a sample of Latinx LGBQ population regarding cancer screening, prevention, and barriers: An exploratory study41
Abstract PR-14: A synergy between the vaginal microbiome and HPV may have explanatory value for racial disparities in risk of pre-cervical cancer39
Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan37
Association between Dietary Anthocyanidins and Biliary Cancer Risk in 98,458 Participants: Results from a Prospective Study35
Adolescent Physical Activity and Breast Cancer Risk in Young Women: Findings From the ProF-SC Study34
Prospective of Mitochondrial DNA Variations in Cancer on Genomic Medicine34
Association Between Clinical, Demographic Factors, and Substance Use Among Young Adult Survivors of Childhood Cancer33
Racial Disparities in Prostate Cancer Mortality Rates Partially Explained By Differences in Dietary and Lifestyle Factors31
Real and Illusory Precision Gains in Meta-Analysis to Speed Action on Carcinogens30
Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank29
Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study29
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa28
Disaggregated Colorectal Cancer Mortality among Asian American Subgroups between 2005 and 202028
Abstract C082: A case of intracranial myeloid sarcoma discovered after a subdural hematoma27
Sex-Specific Outcomes after a Negative Colonoscopy in the Finnish Randomized Health Service Study during 2004–201627
Effects of a Physical Activity mHealth Intervention (Fit2Thrive) on WCRF/AICR Cancer Prevention Recommendations among Breast Cancer Survivors: A Secondary Data Analysis26
Association of Cancer History with COVID-19 Risk and Outcomes among Older Postmenopausal Women: Results from the Women’s Health Initiative26
Abstract B121: Developing organoid model to study drug-resistant breast cancer cells25
Abstract C148: A literature review on patient intervention strategies to improve cancer screening adherence25
Abstract B090: Understanding the impact of health literacy on the perceptions of health misinformation on social media in young adults25
Abstract A027: Acceptability of a culturally adapted mindfulness-based intervention for Hispanic cancer patients and their family caregivers25
Abstract B160: Racial disparities in CAR T-cell therapy utilization and outcomes among patients with diffuse large B-cell lymphoma: A matched cohort study25
Abstract B033: At-risk alcohol intake and clinically meaningful weight loss among overweight/obese Latinos in a nutrition education program25
Abstract B125: Risk of late effects and acute care utilization among childhood, adolescent, and young adult cancer survivors with Medicaid coverage25
0.1540379524231